These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 861728)

  • 1. Involvement of the dopamine nigrostriatal system in the picrotoxin effect on striatal acetylcholine levels.
    Javoy F; Euvrard C; Herbet A; Glowinski J
    Brain Res; 1977 May; 126(2):382-6. PubMed ID: 861728
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs.
    Euvrard C; Labrie F; Boissier JR
    Brain Res; 1979 Jun; 169(1):215-20. PubMed ID: 455094
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat.
    Gundlach AL; Beart PM
    J Pharm Pharmacol; 1981 Jan; 33(1):41-3. PubMed ID: 6114152
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 5. N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.
    Jacobowitz DM; Burns RS; Chiueh CC; Kopin IJ
    Psychopharmacol Bull; 1984; 20(3):416-22. PubMed ID: 6332329
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y; Guyenet P; Glowinski J; Beaujouan JC; Javoy F
    Brain Res; 1975 Mar; 86(3):488-92. PubMed ID: 1116013
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 8. Increase in striatal acetylcholine by picrotoxin in the rat: evidence for a gabergic-dopaminergic-cholinergic link.
    Ladinsky H; Consolo S; Bianchi S; Jori A
    Brain Res; 1976 May; 108(2):351-61. PubMed ID: 945112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals.
    Kelly PH; Joyce EM; Minneman KP; Phillipson OT
    Brain Res; 1977 Feb; 122(2):382-7. PubMed ID: 189878
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
    Javoy F; Euvrard C; Herbet A; Bockaert J; Enjalbert A; Agid Y; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):233-9. PubMed ID: 141623
    [No Abstract]   [Full Text] [Related]  

  • 11. Striatal cholinergic receptors and dyskinetic motor activity in the rat.
    Forchetti C; Scarnati E; Pacitti C; Agnoli A
    Neurosci Lett; 1980 Dec; 20(3):363-7. PubMed ID: 7443082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by GABA of cholinergic transmission in the striatum.
    Scatton B; Bartholini G
    Brain Res; 1980 Feb; 183(1):211-6. PubMed ID: 6244048
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tetanus toxin on transmitter release from substantia nigra and striatum in vitro.
    Collingridge GL; Collins GG; Davies J; James TA; Neal MJ; Tongroach P
    J Neurochem; 1980 Mar; 34(3):540-7. PubMed ID: 7354328
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of acetylcholine and dopamine in myoclonus induced by intrastriatal picrotoxin.
    Slater P; Dickinson SL
    Neurosci Lett; 1982 Mar; 28(3):253-7. PubMed ID: 7078834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
    Scatton B; Boireau A; Garret C; Glowinski J; Julou L
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity of cholinergic neurons to GABAergic and serotoninergic drugs in the rat striatum.
    Javoy-Agid F
    Appl Neurophysiol; 1979; 42(1-2):75-7. PubMed ID: 453807
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of glutamate on the dopamine content and metabolism in the nigrostriatal system of rats differing by their learning capacities].
    Karpova IV; Iakimovskiĭ AF
    Fiziol Zh Im I M Sechenova; 1993 Feb; 79(2):43-51. PubMed ID: 8101122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels.
    Eells JB; Brown T
    Neurotoxicol Teratol; 2009; 31(2):98-103. PubMed ID: 18977431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ethanol on the motor activity of rats and on the content of GABA and dopamine and its metabolites in the nigrostriatal system].
    Karpova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(5):1027-30. PubMed ID: 1336265
    [No Abstract]   [Full Text] [Related]  

  • 20. MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area.
    Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
    Neuropharmacology; 1986 Aug; 25(8):939-41. PubMed ID: 3774119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.